Adare Pharmaceuticals, Inc., and Cincinnati Children’s are joining forces on a project to optimize medications for children.

The collaboration combines the experience of Cincinnati Children’s with Adare’s expertise in enhancing medications and their delivery to improve patient care.

“Collaborations like these drive innovation, and we look forward to working with Cincinnati Children’s to bring better options to infants and children, who have a special set of needs,” says John Fraher, President and CEO of Adare Pharmaceuticals.

According to the agreement, Adare will be part of the review committee for Cincinnati Children’s annual Innovation Fund, which identifies and sponsors research of special merit and potential. Following completion of the chosen research, Adare will have the option of entering into a licensing agreement and will be responsible for further clinical development and commercialization of products arising from the collaboration.

“We are pleased to partner with Adare to identify and advance improved treatments for our patients,” says Margaret Hostetter, MD, Chair of Pediatrics and Director, Cincinnati Children’s Research Foundation.